Practice parameter: Evaluation of the child with global developmental delay: Report of the quality standards subcommittee of the American Academy of Neurology and The Practice Committee of the Child Neurology Society

Neurology

Volumn 60, Issue 3, 2003, Pages 367-380

  Shevell, M ^a,b   Ashwal, Stephen ^c,h   Donley, D ⁱ   Flint, J ^d   Gingold, M ⁱ   Hirtz, D ^e   Majnemer, A ^a   Noetzel, M ^f   Sheth, R D ^g  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c LOMA LINDA UNIVERSITY   (United States)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NONE

Author keywords

[No Author keywords available]

Indexed keywords

LEAD;

ANAMNESIS; ARTICLE; AUDIOMETRY; CHILD DEVELOPMENT; CHROMOSOMAL PARAMETERS; CHROMOSOME REARRANGEMENT; CLINICAL PRACTICE; CYTOGENETICS; DEVELOPMENTAL DISORDER; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; EPILEPSY; EVIDENCE BASED MEDICINE; FACE DYSMORPHIA; FRAGILE X SYNDROME; GENE MUTATION; GENETIC ANALYSIS; HEARING ACUITY; HEARING IMPAIRMENT; HIGH RISK POPULATION; HUMAN; LEAD BLOOD LEVEL; MEDICAL SOCIETY; MOLECULAR GENETICS; NEWBORN SCREENING; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREVALENCE; PRIORITY JOURNAL; RETT SYNDROME; RISK FACTOR; SCREENING; THYROID FUNCTION; VISUAL IMPAIRMENT;

EID: 0037432002     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000031431.81555.16     Document Type: Article

References (123)

1. Simeonsson RJ, Sharp MC. Developmental delays. In: Hoekelman RA, Friedman SB, Nelson NM, et al., eds. Primary pediatric care. St. Louis: Mosby-Year Book, 1992;867-870.
2. Developmental Disabilities Act, 1994 (P.L. 103-230, section 102(8)). Available at: http://www.acf.dhhs.gov/programs/add/DD-ACT2.htm. Accessed October, 2002.
3. Fenichel GM. Psychomotor retardation and regression. In: Clinical pediatric neurology: a signs and symptoms approach, 4th ed. Philadelphia: WB Saunders, 2001;117-147.
4. Simeonsson RJ, Simeonsson NW. Developmental surveillance and intervention. In: Hoekelman RA, Adam HM, Nelson NM, Weitzman ML, Wilson MH, eds. Primary pediatric care, 4th ed. St. Louis: Mosby, 2001;274-282.
5. Kinsbourne M, Graf WD. Disorders of mental development. In: Menkes JH, Sarnat HB, eds. Child neurology, 6th ed. Philadelphia: Lippincott Williams & Wilkins, 2001;1155-1211.
6. Batshaw ML, Shapiro BK. Mental retardation. In: Batshaw ML, ed. Children with disabilities, 4th ed. Baltimore: Paul H. Brookes, 1997;335-359.
7. Majnemer A, Shevell MI. Diagnostic yield of the neurologic assessment of the developmentally delayed child. J Pediatr 1995;127:193-199.
8. Luckasson RL, Coulter DL, Polloway EA, et al. Mental retardation: definition, classification and systems of supports. Washington: AAMR, 1992.
9. Yatchmink Y. Developmental delay: maturational lag to mental retardation. In: Rudolph AM, Hoffman JIE, Rudolph CD, eds. Rudolph's pediatrics, 20th ed. Stamford: Appleton & Lange, 1996;121-124.
10. Petersen MC, Kube DA, Palmer FB. Classification of developmental delays. Semin Pediatr Neurol 1998;5:2-14.
11. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed., text revision. Washington: American Psychiatric Association, 2000;41-49.
12. Johnson JH, Goldman J. Developmental assessment in clinical child psychology. New York: Pergamon Press, 1990.
13. Levine MD, Carey WB, Crocker AC, eds. Developmental-behavioral pediatrics, 3rd ed. Philadelphia: Saunders, 1999.
14. Yeargin-Allsopp M, Murphy CC, Cordero JF, et al. Reported biomedical causes and associated medical conditions for mental retardation among 10 year old children, metropolitan Atlanta, 1985 to 1987. Dev Med Child Neurol 1997;39:142-149.
15. Squires J, Nickel RE, Eisert D. Early detection of developmental problems: strategies for monitoring young children in the practice setting. Dev Behav Pediatr 1996;17:420-427.
16. American Academy of Pediatrics Committee on Children with Disabilities. Developmental surveillance and screening in infants and young children. Pediatrics 2001;108:192-196.
17. Dobos AEJ, Dworkin PH, Bernstein BA. Pediatricians' approaches to developmental problems: has the gap been narrowed? Dev Behav Pediatr 1994;15:34-38.
18. Msall ME, Bier JA, LaGasse L, Tremont M, Lester B. The vulnerable preschool child: the impact of biomedical and social risks on neurodevelopmental function. Semin Pediatr Neurol 1998;5:52-61.
19. Majnemer A. Benefits of early intervention for children with developmental disabilities. Semin Pediatr Neurol 1998;5:62-69.
20. Practice parameters for the assessment and treatment of children and adolescents with language and learning disorders. J Am Acad Child Adolesc Psychiatry 1998;37(10 suppl):46S-62S.
21. Filipek PA, Accardo PJ, Ashwal S, et al. Practice parameter: screening and diagnosis of autism: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Child Neurology Society. Neurology 2000;55:468-479.
22. Shevell MI. The evaluation of the child with a global developmental delay. Semin Pediatr Neurol 1998;5:21-26.
23. Wallerstein R, Seshadri K. Are referrals to developmental pediatricians appropriate? Clin Pediatr 1994;33:564-568.
24. Schaefer GB, Bodensteiner JB. Evaluation of the child with idiopathic mental retardation. Pediatr Clin North Am 1992;39:929-943.
25. Rosenbaum PL. Prevention of psychosocial problems in children with chronic illness. Can Med Assoc J 1988;139:293-295.
26. McLaren J, Bryson SE. Review of recent epidemiological studies of mental retardation: prevalence, associated disorders, and etiology. Am J Ment Retard 1987;92:243-254.
27. Flint J, Wilkie AO. The genetics of mental retardation. Br Med Bull 1996;52:453-464.
28. Shevell MI, Majnemer A, Rosenbaum P, Abrahamowicz M. Etiologic yield of subspecialists' evaluation of young children with global developmental delay. J Pediatr 2000;136:593-598.
29. Battaglia A, Bianchini E, Carey JC. Diagnostic yield of the comprehensive assessment of developmental delay/mental retardation in an institute of child neuropsychiatry. Am J Med Genet 1999;82:60-66.
30. Levy SE, Hyman SL. Pediatric assessment of the child with developmental delay. Pediatr Clin North Am 1993;40:465-477.
31. First LR, Palfrey JS. The infant or young child with developmental delay. N Engl J Med 1994;330:478-483.
32. Curry CJ, Stevenson RE, Aughton D, et al. Evaluation of mental retardation: recommendations of a consensus conference: American College of Medical Genetics. Am J Med Genet 1997;72:468-477.
33. Matilainen R, Airksinen E, Mononen T, Launiala K, Kaariainen R. A population-based study on the causes of mild and severe mental retardation. Acta Paediatr 1995;84:261-266.
34. Henderson HE, Goodman R, Schram J, Diamond E, Daneel A. Biochemical screening for inherited metabolic disorders in the mentally retarded. S Afr Med J 1981;60:731-733.
35. Reinecke CJ, Mienie LJ, Hitzeroth HW, Op't Hof J. Screening for inborn error of metabolism among mentally retarded patients. Outcome of a survey at the Witrand Care and Rehabilitation Center. S Afr Med J 1983;63:14-16.
36. Jaffe M, Borochowitz Z, Dar H. Diagnostic approach to the etiology of mental retardation. Israel J Med Sci 1984;20:136-140.
37. Papavasiliou AS, Bazigou H, Paraskevoulakos E, Kotsalis C. Neurometabolic testing in developmental delay. J Child Neurol 2000;15:620-622.
38. Zytkovicz TH, Fitzgerald EF, Marsden D, et al. Tandem mass spectrometric analysis for amino, organic, and fatty acid disorders in newborn dried blood spots: a two-year summary from the New England Newborn Screening Program. Clin Chem 2001;47:1945-1955.
39. Thomason MJ, Lord J, Bain MD, et al. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Public Health Med 1998;20:331-343.
40. Pollitt RJ, Green A, McCabe CJ, et al. Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess 1997;1:i-iv,1-202.
41. White BJ, Ayad M, Fraser A, et al. A 6-year experience demonstrates the utility of screening for both cytogenetic and FMR-1 abnormalities in patients with mental retardation. Genet Test 1999;3:291-296.
42. Graham SM, Selikowitz M. Chromosome testing in children with developmental delay in whom the aetiology is not evident clinically. J Paediatr Child Health 1993;29:360-362.
43. Volcke P, Dereymaeker AM, Fryns JP, van den Berghe H. On the nosology of moderate mental retardation with special attention to X-linked mental retardation. A diagnostic genetic survey of 274 institutionalized moderately mentally retarded men. Genet Couns 1990;1:47-56.
44. Lamont MA, Dennis NR, Seabright M. Chromosome abnormalities in pupils attending ESN/M schools. Arch Dis Child 1986;61:223-226.
45. Demaerel P, Kingsley DP, Kendall BE. Isolated neurodevelopmental delay in childhood: clinicoradiological correlation in 170 patients. Pediatr Radiol 1993;23:29-33.
46. Crawford DC, Acuna JM, Sherman SL. FMR1 and the fragile X syndrome: human genome epidemiology review. Genet Med 2001;3:359-371.
47. de Vries BBA, Mohkarnsing S, van den Ouweland AMW, et al. Screening for the fragile X syndrome among the mentally retarded: a clinical study. J Med Genet 1999;36:467-470.
48. Sutherland GR. Heritable fragile sites on human chromosomes. IX. Population cytogenetics and segregation analysis of the BrdU-requiring fragile site at 10q25. Am J Hum Genet 1982;34:753-756.
49. Blomquist HK, Gustavson KH, Holmgren G, Nordenson I, Palsson-Strae U. Fragile X syndrome in mildly mentally retarded children in a northern Swedish county. A prevalence study. Clin Genet 1983;24:393-398.
50. Mayer M, Abruzzo MA, Jacobs PA, Yee SC. A cytogenetic study of a population of retarded females with special reference to the fragile (X) syndrome. Hum Genet 1985;69:206-208.
51. Turner G, Brookwell R, Daniel A, Selikowitz M, Zilibowitz M. Heterozygous expression of X-linked mental retardation and X-chromosome marker fra(X)(q27). N Engl J Med 1980;303:662-664.
52. Mingroni-Netto RC, Rosenberg C, Vianna-Morgante AM, Pavanello RD. Fragile X frequency in a mentally retarded population in Brazil. Am J Med Genet 1990;35:22-27.
53. Neri G, Sanfilippo S, Pavone L, et al. The fragile X in Sicily: an epidemiological survey. Am J Med Genet 1988;30:665-672.
54. Proops R, Mayer M, Jacobs PA. A study of mental retardation in children in the Island of Hawaii. Clin Genet 1983;23:81-96.
55. Slaney SF, Wilkie AO, Hirst MC, et al. DNA testing for fragile X syndrome in schools for learning difficulties. Arch Dis Child 1995;72:33-37.
56. Fisch GS, Cohen IL, Jenkins EC, Brown WT. Screening developmentally disabled male populations for fragile X: the effect of sample size. Am J Med Genet 1988;30:655-663.
57. Hagerman RJ, Jackson C, Amiri K, Silverman AC, O'Connor R, Sobesky W. Girls with fragile X syndrome: physical and neurocognitive status and outcome. Pediatrics 1992;89:395-400.
58. Shahbazian MD, Zoghbi HY. Molecular genetics of Rett syndrome and clinical spectrum of MECP2 mutations. Curr Opin Neurol 2001;14:171-176.
59. Leonard H, Bower C, English D. The prevalence and incidence of Rett syndrome in Australia. Eur Child Adolesc Psychiatry 1997;6 suppl 1:8-10.
60. Skjeldal OH, von Tetzchner S, Aspelund F, Herder GA, Lofterld B. Rett syndrome: geographic variation in prevalence in Norway. Brain Dev 1997;19:258-261.
61. Pini G, Milan M, Zappella M. Rett syndrome in northern Tuscany (Italy): family tree studies. Clin Genet 1996;50:486-490.
62. Van Acker R. Rett syndrome: a review of current knowledge. J Autism Dev Disord 1991;21:381-406.
63. Vorsanova SG, Yurov YB, Ulas VY, et al. Cytogenetic and molecular-cytogenetic studies of Rett syndrome (RTT): a retrospective analysis of a Russian cohort of RTT patients (the investigation of 57 girls and three boys). Brain Dev 2001;23 suppl 1:S196-201.
64. Dotti MT, Orrico A, De Stefano N, et al. A Rett syndrome MECP2 mutation that causes mental retardation in men. Neurology 2002;58:226-230.
65. Flint J, Wilkie AO, Buckle VJ, Winter RM, Holland AJ, McDermid HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet 1995;9:132-140.
66. Knight SJ, Flint J. Perfect endings: a review of subtelomeric probes and their use in clinical diagnosis. J Med Genet 2000;37:401-409.
67. Biesecker LG. The end of the beginning of chromosome ends. Am J Med Genet 2002;107:263-266.
68. Knight SJ, Regan R, Nicod A, et al. Subtle chromosomal rearrangements in children with unexplained mental retardation. Lancet 1999;354:1676-1681.
69. Joyce CA, Dennis NR, Cooper S, Browne CE. Subtelomeric rearrangements: results from a study of selected and unselected probands with idiopathic mental retardation and control individuals by using high-resolution G-banding and FISH. Hum Genet 2001;109:440-451.
70. Slavotinek A, Rosenberg M, Knight S, et al. Screening for submicroscopic chromosome rearrangements in children with idiopathic mental retardation using microsatellite markers for the chromosome telomeres. J Med Genet 1999;36:405-411.
71. Colleaux L, Rio M, Heuertz S, et al. A novel automated strategy for screening cryptic telomeric rearrangements in children with idiopathic mental retardation. Eur J Hum Genet 2001;9:319-327.
72. Riegel M, Baumer A, Jamar M, et al. Submicroscopic terminal deletions and duplications in retarded patients with unclassified malformation syndromes. Hum Genet 2001;109:286-294.
73. Rosenberg MJ, Killoran C, Dziadzio L, et al. Scanning for telomeric deletions and duplications and uniparental disomy using genetic markers in 120 children with malformations. Hum Genet 2001;109:311-318.
74. Rossi E, Piccini F, Zollino M, et al. Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations. J Med Genet 2001;38:417-420.
75. Sismani C, Armour JA, Flint J, Girgalli C, Regan R, Patsalis PC. Screening for subtelomeric chromosome abnormalities in children with idiopathic mental retardation using multiprobe telomeric FISH and the new MAPH telomeric assay. Eur J Hum Genet 2001;9:527-532.
76. Clarkson B, Pavenski K, Dupuis L, et al. Detecting rearrangements in children using subtelomeric FISH and SKY. Am J Med Genet 2002;107:267-274.
77. Anderlid BM, Schoumans J, Annérin G, et al. Subtelomeric rearrangements detected in patients with idiopathic mental retardation. Am J Med Genet 2002;107:275-284.
78. Baker E, Hinton L, Callen DF, et al. Study of 250 children with idiopathic mental retardation reveals nine cryptic and diverse subtelomeric chromosomal anomalies. Am J Med Genet 2002;107:285-293.
79. de Vries BB, White SM, Knight SJ, et al. Clinical studies on submicroscopic subtelomeric rearrangements: a checklist. J Med Genet 2001;38:145-150.
80. Needleman HL, ed. Human lead exposure. Boca Raton: CRC Press, 1992.
81. Centers for Disease Control and Prevention. Childhood Lead Poisoning Prevention Program. Available at: http://www.cdc.gov/nceh/lead/lead.htm. Accessed October, 2002.
82. Byers RK, Lord EE. Late effects of lead poisoning on mental development. Am J Dis Child 1943;66:471-494.
83. Bellinger DC, Stiles KM, Needleman HL. Low-level lead exposure, intelligence and academic achievement: a long-term follow-up study. Pediatrics 1992;90:855.
84. de Silva PE, Christophers AJ. Lead level and children's intelligence: do low levels of lead in blood cause mental deficit? J Pediatr Child Health 1997;33:12-17.
85. Tong S. Lead exposure and cognitive development: persistence and a dynamic pattern. J Pediatr Child Health 1998;34:114-118.
86. Mendelsohn AL, Dreyer BP, Fierman AH, et al. Low-level lead exposure and cognitive development in early childhood. J Dev Behav Pediatr 1999;20:425-431.
87. Lamphear BP, Dietrich K, Auinger P, Cox C. Cognitive deficits associated with blood lead concentrations < 10 microg/dL in US children and adolescents. Pub Health Rep 2000;115:521-529.
88. Lewendon G, Kinra S, Nelder R, Cronin T. Should children with developmental and behavioral problems be routinely screened for lead? Arch Dis Child 2001;85:286-288.
89. Kahn CA, Kelly PC, Walker Jr WO. Lead screening in children with attention deficit hyperactivity disorder and developmental delay. Clin Pediatr 1995;34:498-501.
90. Guide to clinical preventive services. Screening for elevated lead levels in childhood and pregnancy. 2nd ed. Baltimore: Williams & Wilkins, 1996;247-267.
91. Screening Children for Lead Exposure in Canada. Ottawa, Canada: Health Canada, 1994;268-288.
92. American Academy of Pediatrics. Screening for elevated blood lead levels. American Academy of Pediatrics Committee on Environmental Health. Pediatrics 1998;101:1072-1078.
93. Tarim OF, Yordam N. Congenital hypothyroidism in Turkey: a retrospective evaluation of 1000 cases. Turk J Pediatr 1992;34:197-202.
94. Illicki A, Larsson A. Psychomotor development of children with congenital hypothyroidism diagnosed by neonatal screening. Acta Paediatr Scand 1988;77:142-147.
95. Willi SM, Moshang Jr T. Results of screening tests for congenital hypothyroidism. Pediatr Clin North Am 1991;38:555-566.
96. Al-Qudah AA. Screening for congenital hypothyroidism in cognitively delayed children. Ann Trop Pediatr 1998;18:285-288.
97. Yaqub BA. Subacute sclerosing panencephalities (SSPE): early diagnosis, prognostic factors and natural history. J Neurol Sci 1996;139:227-234.
98. Franceschetti S, Antozzi C, Binelli S, et al. Progressive myoclonus epilepsies: an electroclinical, biochemical, morphological and molecular genetic study of 17 cases. Acta Neurol Scand 1993;87:219-223.
99. Echenne B, Cheminal R, Rivier F, Negre C, Touchon J, Billiard M. Epileptic electroencephalographic abnormalities and developmental dysphasias: a study of 32 patients. Brain Dev 1992;14:216-225.
100. Sheth RD. Electroencephalogram in developmental delay: specific electroclinical syndromes. Semin Pediatr Neurol 1998;5:45-51.
101. Moeschler JB, Bennett FC, Cromwell LD. Use of the CT scan in the medical evaluation of the mentally retarded child. J Pediatr 1981;98:63-65.
102. Lingam S, Read S, Holland IM, Wilson J, Brett EM, Hoare RD. Value of computerized tomography in children with non-specific mental subnormality. Arch Dis Child 1982;57:381-383.
103. Schouman-Claeys E, Picard A, Lalande G, et al. Contribution of computed tomography in the aetiology and prognosis of cerebral palsy in children. Br J Radiol 1989;62:248-252.
104. Kolawole TM, Patel PJ, Mahdi AH. Computed tomographic (CT) scans in cerebral palsy (CP). Pediatr Radiol 1989;20:23-27.
105. Bouhadiba Z, Dacher J, Monroc M, Vanhulle C, Menard JF, Kalifa G. MRI of the brain in the evaluation of children with developmental delay. J Radiol 2000;81:870-873.
106. Truwit CL, Barkovich AJ, Koch TK, Ferriero DM. Cerebral palsy: MR findings in 40 patients. AJNR Am J Neuroradiol 1992;13:67-78.
107. Van Bogaert P, Baleriaux D, Christophe C, Szliwowski HB. MRI of patients with cerebral palsy and normal CT scan. Neuroradiology 1992;34:52-56.
108. Gabrielli O, Salvolini U, Coppa GV, et al. Magnetic resonance imagining in the malformative syndromes with mental retardation. Pediatr Radiol 1990;21:16-19.
109. Yokochi K, Aiba K, Horie M, et al. Magnetic resonance imaging in children with spastic diplegia: correlation with the severity of their motor and mental abnormality. Dev Med Child Neurol 1991;33:18-25.
110. Routine preschool screening for visual and hearing problems. Canadian guide to clinical preventive health care. Ottawa: Health Canada, 1994;298-304. From the National Guideline Clearinghouse. Available at: http://www.guideline.gov/index.asp. Accessed October, 2002.
111. Guide to clinical preventive services. Screening for visual impairment. 2nd ed. Baltimore: Williams & Wilkins, 1996;373-382. From the National Guideline Clearinghouse. Available at: http://www.guideline-.gov/index.asp. Accessed October, 2002.
112. American Academy of Ophthalmology. Pediatric eye evaluations. 1997. From the National Guideline Clearinghouse. Available at: http://www.guideline.gov/index.asp Accessed October, 2002.
113. Early identification of hearing impairment in infants and young children. NIH Consensus Statement 1993, Mar 1-3;11(1):1-24. Bethesda: National Institute on Deafness and Other Communication Disorders (NIDCD), 1997. From the National Guideline Clearinghouse. Available at: http://www.guideline.gov/index.asp. Accessed October, 2002.
114. Menacker SJ. Visual function in children with developmental disabilities. Pediatr Clin North Am 1993;40:659-674.
115. Folsom RC, Diefendorf AO. Physiologic and behavioral approaches to pediatric hearing assessment. Pediatr Clin North Am 1999;46:107-120.
116. Warburg M. Visual impairment among people with developmental delay. J Intellect Disabil Res 1994;38:423-432.
117. Bachman JA, Bachman WG, Franzel AS, Marcuss MC. Preteaching developmentally delayed preschoolers to aid vision screening. Optom Vis Sci 1994;71:713-716.
118. Kwok SK, Ho PC, Chan AK, Gandhi SR, Lam DS. Ocular defects in children and adolescents with severe mental deficiency. J Intellect Disabil Res 1996;40:330-335.
119. Williamson WD, Desmond MM, Andrew LP, Hicks RN. Visually impaired infants in the 1980s: a survey of etiologic factors and additional handicapping conditions in a school population. Clin Pediatr 1987;26:241-244.
120. Haggard M. Screening children's hearing. Br J Audiol 1992;26:209-215.
121. Rupa V. Dilemmas in auditory assessment of developmentally retarded children using behavioural observation audiometry and brain stem evoked response audiometry. J Laryngol Otol 1995;109:605-609.
122. Richardson MP, Williamson TJ, Lenton SW, Tarlow MJ, Rudd PT. Otoacoustic emissions as a screening test for hearing impairment in children. Arch Dis Child 1995;72:294-297.
123. Vohr BR, Carty LM, Moore PE, Letourneau K. The Rhode Island Hearing Assessment Program: experience with statewide hearing screening. J Pediatr 1998;133:353-357.